New injection HEC-007 enters first human safety trials
NCT ID NCT07102251
First seen Apr 28, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This early-phase study tests the safety and how the body processes a new injection called HEC-007. It involves 126 healthy adults and overweight or obese volunteers. The goal is to check for side effects and measure drug levels, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Anhui Medical University is a Grade A Tertiary General
RECRUITINGHefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.